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ABSTRACT
Objective: This study evaluated the blood and uterine tissue concentration of mezlocillin, a broad-
spectrum penicillin.
Methods: We adapted a liquid chromatographic method to measure mezlocillin in serum and
tissue. Mezlocillin reference standard was diluted in water, chromatographed on a reversed phase
C18 column eluted at 1.5 ml/min with acetonitrile and phosphate buffer (1:3 v:v), and detected
spectrophotometrically at 210 nm. Mezlocillin was administered to 14 premenopausalwomen sched-
uled to undergo vaginal hysterectomy. Each patient received a 4 g IV infusion of the drug 30 to 60
min prior to surgery. During surgery, tissue was removed from the uterine cervix and blood was
obtained for assay of mezlocillin content.
Results: Chromatography of the mezlocillin standard furnished a discrete peak with a retention
time of 2.4 min. The sensitivity of the assay was 0.1 pg/ml with a linear response up to 100 g/ml.
The correlation coefficient for the standard curve was 0.9997. When reference standard was diluted
in pooled human serum, the assay was complicated by interfering compounds. These were removed
by ether extraction. The sensitivity of the assay performed in serum was 3 Cg/ml. Serum samples
contained from 81.2 to 358 pg ofmezlocillin/ml with an average serum concentration of207.5 g/ml.
When serum containing a known amount of mezlocillin was homogenized for a period of time
similar to that required to homogenize tissue samples, a detectable loss of drug was observed and
was applied as a correction factor to the measured tissue levels. After correction, the average tissue
level was 117.2 g/ml and ranged from 27% to 98% of the serum levels.
Conclusions: The serum concentration ofmezlocillin after IV infusion of4 g was greater than that
required to inhibit the majority of the most significant organisms responsible for post-hysterectomy
sepsis. Although tissue levels appeared to be consistently lower than serum levels, they could be
expected to provide an inhibitory effect against many of the bacterial strains that contaminate the
surgical site. (C) 1993 Wiley-Liss, Inc.
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otent broad-spectrum congeners of penicillin
are finding increasing use in a variety of clinical
settings. The rational use ofsuch antibacterial agents
requires knowledge of the pharmacokinetics and
pharmacodynamics of these drugs. Sensitive meth-
ods for assaying drugs in serum or tissue are needed
for developing such information, and high perfor-
mance liquid chromatography (HPLC) has become
a useful technique for obtaining such information.
The present study adapted an HPLC method for
analysis of serum and tissue samples from patients
treated with rnezlocillin. HPLC methods for de-
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termination of the related compounds mezlocillin
and azlocillin in plasma have been reported, but
these methods have not been tailored for use with
tissue. The methods available for measuring plasma
levels were evaluated and adapted for use with se-
rum and tissue specimens.
MATERIALS AND METHODS
Mezlocillin as the sodium salt with a potency of
920 Ixg/mg was provided by Miles Pharmaceuticals
(New Haven, CT). The drug was reconstituted
with distilled water to make a stock solution of
100.28 txg/ml. Stock solutions were stored at
-74C.
The 14 patients studied were scheduled to un-
dergo vaginal hysterectomy and were given preop-
erative prophylaxis consisting of 4 g mezlocillin
dissolved in 500 ml of normal saline by IV infu-
sion. The antibiotic infusion was started within
hr of the time the surgical procedure began.
During the surgical procedure, when the uterus
was being removed, a blood sample was drawn
from the antecubital vein, and the blood was al-
lowed to clot. A section was cut from the uterine
cervix, and both blood and tissue were transported
to the laboratory, where the serum was removed
from the clot and serum and tissue stored at -74C
until analysis.
The method for tissue and serum analysis was
established experimentally (see Results). Prior to
assay, tissue and blood samples were thawed at room
temperature. Approximately 0.25 g was cut from
the tissue sample, weighed to the nearest 0.1 mg,
minced, and placed in a tube containing 3 ml of
water. These samples were kept on ice until the
tissue was liquified with a Tekmar tissue homoge-
nizer (Tekmar, Cincinnati, OH). The homoge-
nate was deproteinized by the addition of 5 ml
acetonitrile, followed by centrifugation for 15 min
at 2,000g. The supernatant fluid was removed and
extracted 3 times with 3 ml of diethyl ether. The
aqueous phase was then injected onto the chromato-
graph.
The serum samples were deproteinized with
equal volumes of acetonitrile, centrifuged at 2,000g
for 15 min, and extracted 3 times with 2.5 volumes
of diethyl ether. The aqueous phase was chromato-
graphed.
Samples were analyzed by I--IPLC on a 4.6
220 mm octadecyl silyl, 5 Im particle size column
with a guard column of identical composition. Sam-
ples of 20 Ixl were injected and eluted with 1:3
acetonitrile:0.01 M potassium dihydrogen phos-
phate buffer, pH 7, at a flow rate of 1.5 ml/min.
The column effluent was monitored spectrophoto-
metrically at 210 nm. Except where specifically
noted, all measurements were made by triplicate
determinations on each sample, and the identity of
mezlocillin was based on retention time while quan-
titation was based on peak height.
Dilutions of mezlocillin standard were made in
water or pooled human serum to determine linear-
ity, repeatability, and sensitivity of the assays. Stan-
dard curves made in serum were used to establish
drug levels in the patient specimens.
A control to determine whether drug may have
been lost during the process of tissue disruption was
prepared. Serum containing a known amount of
mezlocillin was homogenized for a period of time
equal to the time required to disrupt the tissue
samples. This control was then subjected to depro-
teinization and ether extraction as for other sam-
ples. The peak height obtained from this sample
was compared with the result obtained from a se-
rum sample with an identical concentration of me-
zlocillin that had not undergone homogenization.
This provided a correction factor that was applied
to tissue concentrations to correct for drug loss due
to tissue homogenization.
RESULTS
Figure shows that the mezlocillin standard di-
luted in water produced a symmetrical peak with a
retention time of 2.4 min. Thus, the chromato-
graphic method used was deemed acceptable for
detecting the pure compound.
A series ofdilutions of mezlocillin standard from
0.1 Ixg/ml to 100.28 Ixg/ml were made in water to
allow determination of the sensitivity and linearity
of the assay method. The smallest concentration
detected was 0.1 Ig/ml, which furnished an aver-
age peak height of 0.00083 absorbance units at 210
nm. The assay was linear over the full range of
concentrations and provided a correlation coeffi-
cient (r2) Of 0.9997.
Ten replicate chromatograms of a standard con-
taining 100.28 Ixg mezlocillin standard/ml were
evaluated to determine the repeatability of peak





Fig. I. Mezlocillin (MEZ) reference standard diluted in wa-
ter chromatographed on a reversed phase column under
conditions described in the Materials and Methods section. A
single symmetrical peak representing the pure compound
was observed. Chromatography of a larger concentration
revealed a linear relationship between peak height and con-
centration.
height and retention time. The average retention
time was 2.40 + 0.024 rain (SD). The average
peak height was 0.774 + 0.0118 absorbance units
(SD). The coefficient of variation (relative SD) for
retention time was 1% and for peak height was
1.5%. The procedure was therefore considered to
be highly repeatable.
The methods for preparation of serum samples
for chromatographic determination of mezlocillin
were evaluated. A known concentration of mezlocil-
lin was added to a pool of human serum, and vari-
ous methods were used to prepare aliquots of that
serum for analysis. The first method involved ad-
dition of ml of 5% perchloric acid to ml of the
serum sample followed by centrifugation. This pro-
vided a protein-free sample for chromatography.
As illustrated in Figure 2, this method of prepara-
tion was unsuitable because exposure to perchloric
acid appeared to generate at least two new peaks,
which may have been degradation products of me-
zlocillin. Furthermore, it was not possible to iden-
tify the mezlocillin peak unequivocally in the acid-
treated serum.
The second method of sample preparation em-
ployed the addition of ml of acetonitrile to ml of
serum to precipitate the protein from the sample. It
was believed that the acetonitrile would be less likely
to cause degradation of the mezlocillin than would
perchloric acid. However, the protein-free super-
natant fluid from acetonitrile-treated serum yielded
a chromatogram similar to that obtained when se-
rum without mezlocillin was treated with acetoni-
trile. This finding suggested that the mezlocillin was
being masked by some component of the serum.
It was subsequently found that diethyl ether ex-
traction removed the interfering compounds from
the acetonitrile-precipitated samples, as shown in
Figure 3. In addition, the acetonitrile entered the
ether phase, which eliminated the dilution of the
sample due to the deproteinization step. Consequently,
the acetonitrile precipitation followed by ether extrac-
tion was adopted for sample preparation.
When standards prepared in water, treated with
acetonitrile, and extracted with ether were com-
pared with standards diluted in water, no apprecia-
ble loss of drug due to the extraction procedure was
observed. Recoveries ranged from 97.7% to 106%
for the concentrations of mezlocillin observed in
the patient samples. Based on these findings, stan-
dard curves for mezlocillin assay were prepared in
pooled serum, and patient samples were compared
with these standards.
Tissue samples were also compared with a stan-
dard curve prepared in serum. However, it was
determined that the tissue homogenization was ex-
pected to have reduced the amount of mezlocillin
detectable by 37.5% based on homogenizing serum
samples with added mezlocillin. As a consequence
of this finding, the observed tissue values were
increased by a factor of 0.375.
The serum and tissue levels observed in the 14
patients studied are summarized in Table 1. The
levels observed in serum were consistently higher
than those found in tissue. The highest serum levels
tended to be associated with the highest tissue lev-
els, but the relationship of serum to tissue levels
revealed an r
2 of 0.58.
This study was not designed to be a pharmaco-
kinetic study, but rather an evaluation of the serum
and tissue levels obtained simultaneously after IV
infusion. Therefore, the time after infusion that the
tissue sample was removed and the serum sample
was taken was not identical in each case and varied
from 5 rain to 130 min. In the limited number of
samples available in the study, no linear correlation
between the time after infusion and tissue or serum
levels was apparent.
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Fig. 2. Evaluation by chromatograms of perchloric acid precipitation for preparation of serum
samples. A: Mezlocillin (MEZ) standard (6.25 Ig/ml, final concentration) diluted in water with a
retention time of approximately 2.4 min. B: Mezlocillin, 6.25 Ig/ml, with 2.5% perchloric acid. The
height of the mezlocillin peak was diminished (compared with A), and multiple new peaks appeared,
suggesting degradation products’ (2: Mezlocillin, 6.25 Ig/ml (final concentration), in serum deprotein-
ized with perchloric acid, showing that mezlocilin is obscured by serum components. S: Start of each
chromatographic run.
DISCUSSION
The use of antimicrobial prophylaxis in such surgi-
cal procedures as vaginal or abdominal hysterec-
tomy is so common that one may be tempted to
consider studies involving prophylaxis as trivial.
Despite the frequent application of prophylaxis, the
fundamental reasons why this type of drug use is
effective is still a matter of conjecture. It is assumed
that antibiotics administered preoperatively affect
microorganisms that contaminate the operative site,
but it is not clear whether any of the organisms are
killed, prevented from replicating, or simply pre-
vented from producing virulence factors. It is like-
wise not clear what relevance in vitro minimal in-
hibitory concentrations have for these tissues. The
length of time and concentration of drug required
to be present in the tissue for effective prophylaxis
TIME
Fig. 3. A: Pattern obtained when ether-extracted serum is
chromatographed. B: Results when the serum is spiked with
mezlocillin (M) standard and extracted with ether. The me-
zlocillin produces a resolved and quantifiable peak.
74 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYMEZLOCILLIN IN TISSUE MYA ET AL.
TABLE I. Observed concentrations of mezlocillin in
serum and uterine cervix from women given 4 g of




Mean 117.2 207.5 0.567
Standard 66.9 93.0 0.233
deviation
Range 27.5-228. 81.2-358.0 0.268-0.982
are also open to question. Analysis of tissue levels of
various antimicrobials as well as serum levels rep-
resents a necessary tool for enhancing our under-
standing of the effects of prophylaxis at the opera-
tive site.
The work presented here adapted a chromato-
graphic procedure for use in determining the se-
rum and tissue levels of mezlocillin. An attempt
was made to take into account the possibility that
interaction of the drug with tissue or serum compo-
nents may reduce the amount of drug apparent in
our assays. It cannot be claimed that subjecting
mezlocillin-spiked serum to the homogenization
step provided a true .control for possible loss in
tissue samples, although the data suggest that such
an observation is not irrelevant. An ideal study
would have added drug to tissue from a patient not
treated with antibiotic and processed the tissue as
described; however, obtaining tissue samples from
patients who had not received the drug was outside
the bounds of the protocol approved by the IRB,
leaving the serum homogenization test as the sub-
optimal alternative. Certainly, any future applica-
tion of this method could be improved by including
a control using tissue from a patient not exposed to
antibiotic.
The question of why the homogenizing proce-
dure made a portion of the drug unrecoverable is
not explained by the studies presented. Oxidative
damage to the drug or some irreversible reaction
with protein or other constituents of the biological
matrix are potential explanations. The possibility
that drug was incorporated into micelles during the
homogenization process may be less likely, since
the solvent extraction steps should destroy such
structures.
In view of the above considerations, it may be
stated that in all cases, some mezlocillin was present
in uterine tissue at the time of incision, and the
tissue concentration was at least one quarter that
present in serum if one accepts the correction fac-
tor. A more conservative estimate (without the cor-
rection factor) of tissue concentrations ranges from
17.2 to 142.5 txg/g and would average 35% of the
simultaneous tissue values.
For therapy of established infections, it is desir-
able to achieve serum and tissue concentrations
greater (generally by 2-4 times) than the minimal
inhibitory concentrations of the etiologic agents.
Somewhat less certain are the serum or tissue levels
required to achieve prophylaxis against infection of
the operative site. It is not clear whether it is neces-
sary to achieve minimal inhibitory concentrations
against microorganisms at the surgical site. The
levels of mezlocillin observed in serum and tissue
are well above the minimal inhibitory concentra-
tions reported for some ofthe microorganisms com-
monly involved in infections after hysterectomy.
2
For example, 90% of Bacteroidesfragilis strains are
inhibited by 32 Ig of mezlocillin/ml and 90% of
Escherichia coli strains are inhibited by 64 Ig/ml.
It should be noted, however, that minimal inhibi-
tory concentrations are determined in vitro with a
constant concentration of drug and with the test
organism exposed to that drug for many hours. In
the patient, the concentration of the drug is con-
stantly changing. The present study, not being a
pharmacokinetic study, did not sample tissue and
serum at identical times after infusion. Thus, while
significant levels of antibiotic were detected in the
patients studied, future work will need to elucidate
the relevance of brief exposures of microorganisms
to these concentrations of mezlocillin. This chro-
matographic technique has proved an appropriate
tool in establishing the concentration of mezlocillin
to be studied in future investigations.
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